Papers
14
Total Citations
298
H-Index
9
About
Hiroshige Nakamura is a pioneering thoracic surgeon whose career has been defined by his tireless advocacy for minimally invasive surgical approaches, particularly robot-assisted thoracoscopic surgery (RATS) in the treatment of lung cancer and mediastinal disease. As one of Japan's earliest adopters of robotic thoracic surgery, Nakamura has played a foundational role in establishing the safety, feasibility, and clinical advantages of RATS within the Japanese medical landscape, documenting the nation's initial results and learning curves at a time when the technology lacked national health insurance coverage. His comparative research — examining RATS against conventional video-assisted thoracoscopic surgery (VATS) for lobectomy, anatomical segmentectomy, and critically, lymph node dissection — has helped build the evidence base clinicians rely on when choosing surgical approaches for lung cancer patients. His 2020 survival outcomes study (41 citations) and lymph node dissection comparison (33 citations) are particularly influential contributions to this field. Beyond oncological surgery, Nakamura has extended his vision to telesurgery, co-authoring the landmark 2022 Clinical Practice Guidelines (36 citations), addressing surgical access equity and education. Together, his body of work represents a sustained commitment to advancing precision, safety, and accessibility in thoracic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2Robot-assisted thoracoscopic surgery: current status and prospects39 citations · 2012
- 3Clinical practice guidelines for telesurgery 202236 citations · 2024
- 4
- 5Initial results of robot-assisted thoracoscopic surgery in Japan33 citations · 2014
- 6
- 7A Successful Case of Robotic Bronchoplastic Lobectomy for Lung Cancer29 citations · 2012
- 8
- 9
- 10